| 注册
首页|期刊导航|湖南中医药大学学报|二陈汤合六君子汤化裁联合常规西医治疗慢性阻塞性肺疾病急性加重期疗效观察

二陈汤合六君子汤化裁联合常规西医治疗慢性阻塞性肺疾病急性加重期疗效观察

边哨 沈珊 吴安源 王增玲

湖南中医药大学学报2025,Vol.45Issue(5):904-909,6.
湖南中医药大学学报2025,Vol.45Issue(5):904-909,6.DOI:10.3969/j.issn.1674-070X.2025.05.017

二陈汤合六君子汤化裁联合常规西医治疗慢性阻塞性肺疾病急性加重期疗效观察

Efficacy observation of modified Erchen Decoction and Liujunzi Decoction combined with conventional western medicine therapy on acute exacerbation of chronic obstructive pulmonary disease

边哨 1沈珊 1吴安源 1王增玲2

作者信息

  • 1. 合肥市第八人民医院中医科,安徽 合肥 238000
  • 2. 吉林省中医药科学院(吉林省中医药科学院第一临床医院),吉林长春 130012
  • 折叠

摘要

Abstract

Objective To explore the efficacy of modified Erchen Decoction and Liujunzi Decoction combined with conventional western medicine therapy in treating acute exacerbation of chronic obstructive pulmonary disease(AECOPD)(phlegm dampness accumulating in the lung pattern).Methods A total of 136 AECOPD patients with phlegm dampness accumulating in the lung pattern admitted to the Eighth People's Hospital of Hefei from January 2022 to January 2024 were selected and randomly divided into observation group and control group.The control group received conventional western medicine therapy,while the observation group received oral administration of modified Erchen Decoction and Liujunzi Decoction in addition to the treatment provided to the control group.Clinical efficacy,TCM pattern scores,blood gas parameters,lung function indicators,COPD Assessment Test(CAT)scores,6-minute walking distance(6MWD),serum levels of CX chemokine ligand 10(CXCL10)and CX3 chemokine ligand 1(CX3CL1)before and after treatment were compared between the two groups,and the safety of medication was analyzed as well.Results The total effective rate of the observation group was higher than that of the control group(P<0.01).Compared with before treatment,TCM pattern scores,CAT scores,arterial partial pressure of carbon dioxide(PaCO2),and serum levels of CXCL10 and CX3CL1 decreased in both groups after treatment(P<0.01),and the above indicators in the observation group were lower than those in the control group(P<0.01).Compared with before treatment,both groups showed increased arterial partial pressure of oxygen(PaO2),forced expiratory volume in one second to forced vital capacity(FEV/FVC)ratio,FEV1 to the predicted value(FEV1%pred),and 6MWD after treatment(P<0.01),and the above indicators in the observation group were higher than those in the control group(P<0.01).During treatment,no obvious adverse events occurred in either group.Conclusion For AECOPD patients with phlegm dampness accumulating in the lung pattern,the treatment with modified Erchen Decoction and Liujunzi Decoction can relieve clinical symptoms,improve pulmonary ventilation function,enhance the quality of life,and reduce the serum levels of CXCL10 and CX3CL1,exhibiting significant efficacy and high safety.

关键词

二陈汤/六君子汤/慢性阻塞性肺疾病急性加重期/痰浊阻肺证/疗效/趋化因子

Key words

Erchen Decoction/Liujunzi Decoction/acute exacerbation of chronic obstructive pulmonary disease/phlegm dampness accumulating in the lung pattern/therapeutic effect/chemokine

分类

医药卫生

引用本文复制引用

边哨,沈珊,吴安源,王增玲..二陈汤合六君子汤化裁联合常规西医治疗慢性阻塞性肺疾病急性加重期疗效观察[J].湖南中医药大学学报,2025,45(5):904-909,6.

基金项目

2022年中医药古籍文献和特色技术传承专项项目(GZY-KJS-2022-030). (GZY-KJS-2022-030)

湖南中医药大学学报

1674-070X

访问量5
|
下载量0
段落导航相关论文